Fetal Monitoring Market

The global fetal monitoring market in terms of revenue was estimated to be worth $3.7 billion in 2022 and is poised to reach $5.2 billion by 2027, growing at a CAGR of 7.3% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The advancements in technologies for fetal monitoring systems, and the growing number of obstetrics and gynecology centers are the major factors driving the market’s growth.

Attractive Opportunities in the Fetal monitoring Market

e- estimated, p-projected

To know about the assumptions considered for the study, Request for Free Sample Report

Fetal Monitoring Market Dynamics

Driver: Rising number of preterm births and increasing adoption of infertility treatment

Many research types have shown that the incidence of preterm births is growing due to hypertension, prolonged pre-labor rupture of membranes, antepartum hemorrhage, multiple gestations, assisted reproductive technology, short cervixes, Urinary Tract Infections (UTIs), and placenta previa, among others. There has been an adoption of advanced medical technologies in fetal monitoring systems due to The rising number of preterm births, according to the WHO, an estimated 15 million preterm births occur every year and approximately 1 million babies die each year right after birth, and the numerous neurological or physical disabilities that follow preterm births are a grave concern.

Opportunity: Development of non-invasive, portable, and advanced fetal monitors

The key manufacturers in the market are expanding their product lines to include portable and wireless monitoring systems that are accurate, safe, and affordable. For instance, in November 2021, the Shantou Institute of Ultrasonic Instruments Co., Ltd. (China) launched the Apogee 6 series of color Doppler ultrasound imaging solutions. This series included the Apogee 6200, Apogee 6300, and Apogee 6500 color Doppler ultrasound systems, that provides a solution for cardiac, abdominal, vascular, musculoskeletal, urology, and OB/GYN clinical applications.

Restraint: Availability of refurbished products

The major restraint for the growth of this market is the availability of refurbished fetal monitoring products. The companies that offer refurbished fetal monitoring products are CeviMed, SOMA TECH, Jaken Medical, and Absolute Medical Services. For cost-effectiveness various small and medium-sized hospitals opt for refurbished systems, particularly in developing countries which are price-sensitive markets. Due to these factors, there is surge in the demand for refurbished fetal monitoring and it is expected to rise in the coming years, as all these refurbished equipments offer the same functionalities as new equipment but at lower costs. This factor will hamper the revenue of companies that are offering branded fetal monitoring products in the market.

Challenge: Lack of skilled healthcare professionals

Recently, there is a shortage of professionals to deliver obstetrics, gynecology, and other preventive and reproductive healthcare services, predominantly specializing in women's health. According to The American College of Obstetricians and Gynecologists (ACOG), the demand for obstetrics and gynecology professionals is expected to increase from 50,850 to 52,660 (4%) by 2030. This means that obstetrics and gynecology efforts could increasingly focus on high-risk pregnancies, the management of complex gynecological conditions, and surgical procedures.

The market is moderately consolidated. The top players— GE Healthcare (US), Siemens Healthineers (Germany), Koninklijke Philips N.V. (Netherlands), FUJIFILM SonoSite, Inc. (US), and Cardinal Health, Inc. (US)-in the market accounted for a combined majority market share in 2021. There is a high degree of competition among the market players. Only major companies can afford high-capital investments as well as the high cost of R&D and manufacturing. This will prevent new entrants from entering this market.

Ultrasound devices segment accounted for the largest share of the fetal monitoring industry, by products

The fetal monitoring market is segmented into ultrasound devices, electronic maternal/fetal monitors, fetal electrodes, fetal doppler devices, uterine contraction monitors, telemetry devices, accessories & consumables, and other products. Ultrasound accounts for the major share in this market due to the increasing demand for minimally invasive gynecological treatments, and large use of ultrasound in obstetrics.

Non-portable systems segment accounted for the largest share in the fetal monitoring industry, by portability

The fetal monitoring market has been segmented into non-portable systems and portable systems. The non-portable systems segment accounted for the largest share of the market. Factor such as the large use of non-portable systems in hospitals and clinics which are the major end users is driving the growth of the market.

Non-invasive segment accounted for the largest share in the fetal monitoring industry, by method

The fetal monitoring market has been segmented into invasive and non-invasive. The non-invasive segment accounted for the largest share of the market. The increasing incidence of high-risk pregnancies, coupled with ongoing research activities and the launch of innovative products are the factors driving the market growth.

Antepartum segment accounted for the largest share in the fetal monitoring industry, by application

The fetal monitoring market has been segmented into antepartum and intrapartum. The antepartum segment accounted for the largest share of the market. Antepartum is the longest time period of gestation period for fetal monitoring to diagnose any fetal abnormalities, thus, driving the market growth.

Hospitals segment accounted for the largest share in the fetal monitoring industry, by end user

The fetal monitoring market has been segmented into hospitals, obstetrics & gynecology clinics, and home care settings. The hospitals segment accounted for the largest share of the market. The rising government healthcare expenditure, and availability of high end facilities are the factors driving the market growth.

North America is the largest region for fetal monitoring industry.

The global fetal monitoring market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. North America was the largest regional market for fetal monitoring. The availability of experts and availability of Neonatal Intensive Care Units (NICUs) are the major factors that supports the growth of the market in North America. However, the Asia Pacific region offers high-growth opportunities for players in the market. This regional segment is projected to register the highest CAGR during the forecast period. Factors such as low-weight births, and rising number of marital age individuals due to which there will be more number of pregnancies are factors driving the market growth in the region.

To know about the assumptions considered for the study, download the pdf brochure

Some key players in the fetal monitoring market are:

• GE Healthcare (US)
• Siemens Healthineers (Germany)
• Koninklijke Philips N.V. (Netherlands)
• FUJIFILM SonoSite, Inc. (US)
• Cardinal Health, Inc. (US)

Scope of the Fetal Monitoring Industry

This report categorizes the fetal monitoring market to forecast revenue and analyze trends in each of the following submarkets:

By Product

• Ultrasound Devices
• Electronic Maternal/Fetal Monitors
• Uterine Contraction Monitor
  • 2D Ultrasound
  • 3D/4D Ultrasound
  • Doppler Imaging
• Fetal Electrodes
• Fetal Doppler Devices
• Telemetry Devices
• Accessories and Consumables
• Other Products

By Portability

• Portable systems
• Non-portable systems

By Method

• Invasive
• Non-Invasive

By Application

• Antepartum
• Intrapartum

By End User

• Hospitals
• Obstetrics and Gynecology Clinics
• Home Care Settings

By Region

• North America
  • US
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• Rest of the World
  • Latin America
  • Middle East & Afric

Recent Developments of Fetal Monitoring Industry

• In May 2022, GE Healthcare (US) and Pulsenmore (Israel) signed an agreement to accelerate the adoption of Pulsenmore's home care ultrasound solutions and support their goal to pursue US FDA clearance and commercial expansion.
• In April 2022, ArchiMed Group (France) acquired Natus Medical Incorporated (US) to expand the reach and breadth of Natus' market-leading products, reinforcing the focus on research & development and pursuing acquisitions of complementary businesses.
• In March 2021, CONTEC Medical Systems Co., Ltd. (China) launched CMS1700B Color Doppler Ultrasonic Diagnostic System, which is mainly suitable for the diagnosis of problems in the abdomen, heart, peripheral vessels, breast, obstetrics and gynecology, small organs, urology, muscle, incretion, pediatrics, etc.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst